BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22190224)

  • 1. CYP1B1 Leu432Val polymorphism and colorectal cancer risk among Caucasians: a meta-analysis.
    Xie Y; Liu GQ; Miao XY; Liu Y; Zhou W; Zhong DW
    Tumour Biol; 2012 Jun; 33(3):809-16. PubMed ID: 22190224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP1B1 Asn453Ser polymorphism and colorectal cancer risk: a meta-analysis.
    Mei Q; Zhou D; Han J; Lu H; Tang B
    Metabolism; 2012 Sep; 61(9):1321-9. PubMed ID: 22459615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSTP1 Ala114Val polymorphism and colorectal cancer risk: a meta-analysis.
    Li F; Xu B; Yang Z; Wu Y; Dong S; Qian J
    Tumour Biol; 2013 Jun; 34(3):1825-31. PubMed ID: 23504587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSTP1 Ile105Val polymorphism and colorectal cancer risk: an updated analysis.
    Tan Z; Feng M; Luo Y; Sun C; Fan Z; Tan Y; Fu B; Lang J
    Gene; 2013 Sep; 527(1):275-82. PubMed ID: 23811488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor BsmI polymorphism and colorectal cancer risk: an updated analysis.
    Yu K; Yang J; Jiang Y; Song R; Lu Q
    Asian Pac J Cancer Prev; 2014; 15(12):4801-7. PubMed ID: 24998544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between IL-1 family gene polymorphisms and colorectal cancer: A meta-analysis.
    Liu L; Zhai Z; Wang D; Ding Y; Chen X; Wang Q; Shu Z; Wu M; Chen L; He X; Fan D; Pan F; Xing M
    Gene; 2021 Feb; 769():145187. PubMed ID: 32998046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CYP1B1 Leu432Val polymorphism and risk of urinary system cancers.
    Liu Y; Lin CS; Zhang AM; Song H; Fan CC
    Tumour Biol; 2014 May; 35(5):4719-25. PubMed ID: 24453031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CYP1B1 gene polymorphisms with susceptibility to endometrial cancer: a meta-analysis.
    Wang F; Zou YF; Sun GP; Su H; Huang F
    Eur J Cancer Prev; 2011 Mar; 20(2):112-20. PubMed ID: 21191305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis.
    Cui L; Dillehay K; Chen W; Shen D; Dong Z; Li W
    Mol Biol Rep; 2012 Jul; 39(7):7465-71. PubMed ID: 22327650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between CYP1A2 and CYP1B1 polymorphisms and colorectal cancer risk: a meta-analysis.
    He XF; Wei J; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Si HQ; Liu Q; Wu LX; Wei W
    PLoS One; 2014; 9(8):e100487. PubMed ID: 25115775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catechol-O-methyltransferase and cytochrome P-450 1B1 polymorphisms and endometrial cancer risk: a meta-analysis.
    Teng Y; He C; Zuo X; Li X
    Int J Gynecol Cancer; 2013 Mar; 23(3):422-30. PubMed ID: 23370603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.
    Liu F; Yuan D; Wei Y; Wang W; Yan L; Wen T; Xu M; Yang J; Li B
    PLoS One; 2012; 7(8):e43821. PubMed ID: 22928041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P21 Ser31Arg polymorphism and cervical cancer risk: a meta-analysis.
    Li Y; Liu F; Tan S; Li S
    Int J Gynecol Cancer; 2011 Apr; 21(3):445-51. PubMed ID: 21430453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between the hOGG1 1245C>G (rs1052133) Polymorphism and Susceptibility to Colorectal Cancer: a Meta-analysis Based on 7010 Cases and 10,674 Controls.
    Ghelmani Y; Asadian F; Antikchi MH; Dastgheib SA; Shaker SH; Jafari-Nedooshan J; Neamatzadeh H
    J Gastrointest Cancer; 2021 Jun; 52(2):389-398. PubMed ID: 33025423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CYP1B1 Leu432Val polymorphism contributes to lung cancer risk: evidence from 6501 subjects.
    Chen B; Qiu LX; Li Y; Xu W; Wang XL; Zhao WH; Wu JQ
    Lung Cancer; 2010 Dec; 70(3):247-52. PubMed ID: 20395011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies.
    Peng Q; Yang S; Lao X; Tang W; Chen Z; Lai H; Wang J; Sui J; Qin X; Li S
    PLoS One; 2014; 9(4):e94790. PubMed ID: 24733273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between the CYP1B1 C4326G polymorphism and endometrial cancer risk: a meta-analysis.
    Wang XW; Chen YL; Luo YL; Liu QY
    Asian Pac J Cancer Prev; 2011; 12(9):2343-8. PubMed ID: 22296381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
    Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of the influence of CYP1B1 polymorphisms and head and neck squamous cell carcinoma risk.
    Shen M; Hu YY; Hu YK; Xie LC; Xu XM; Wu MY; Niu YM
    Tumour Biol; 2014 Apr; 35(4):3891-7. PubMed ID: 24343338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls.
    Yang J; Xu DL; Lu Q; Han ZJ; Tao J; Lu P; Wang C; Di XK; Gu M
    Asian J Androl; 2012 Jul; 14(4):560-5. PubMed ID: 22504876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.